Keshil Acid 500 Mg (Doberic Acid Calcium Hydrate)

Adult dose

Adults: Administer the following doses of calcium dobesilate hydrate orally. 1. Vascular damage and retinopathy: 500~1000mg per day 2. Venous disease: Administer 750mg per day for 1~3 weeks, then administer 500mg per day. Administer after meals with plenty of fluids. Adjust the dose as appropriate according to age and symptoms.

This drug contains Doberic Acid Calcium Hydrate as its main ingredient and is used for the treatment of various diseases. First, this drug should not be used by individuals who are allergic to Doberic Acid Calcium Hydrate or any of the other ingredients in this drug. Women who are pregnant or breastfeeding should also not take this drug. In addition, since it contains lactose, patients with genetic lactose intolerance, lactose enzyme deficiency, or glucose-galactose malabsorption should not take this drug. Patients with impaired kidney function should use this drug cautiously. In particular, patients with severe kidney failure requiring dialysis may need dosage reduction. Patients with compromised liver function also require caution when taking this drug, and if liver enzyme levels rise, the effectiveness of treatment should be re-evaluated. This drug contains sodium sulfite, which may cause allergic reactions in some individuals. In particular, asthmatic patients are more sensitive to sulfites, which increases the risk of asthma attacks. During treatment, symptoms such as headache, abdominal pain, nausea, diarrhea, vomiting, joint pain, and muscle pain may commonly occur. An increase in liver enzyme levels indicating liver dysfunction may also occur. If allergic symptoms such as skin rash, itching, hives, or facial swelling appear, the medication should be stopped immediately. Very rarely, a serious blood condition known as agranulocytosis may develop, which can present with high fever or symptoms of infection, so if these symptoms occur, consult a doctor immediately. Moreover, this drug can cause serious adverse reactions such as anaphylactic shock, so if an allergic reaction is suspected, discontinue use immediately and notify healthcare professionals. No specific interactions with other drugs are known, but it should be informed to the healthcare professionals before the examination, as creatinine levels may appear lower than they actually are during blood tests. Before taking this drug, necessary tests including blood tests should be conducted to use it safely.

• agranulocytosis
• neutropenia
• leukopenia
• skin rash
• allergic dermatitis
• itching
• hives
• facial swelling
• anaphylactic reaction
• headache

This drug is sensitive to light and should be stored in a tightly closed container that blocks light. It is important to keep the storage temperature between 1 and 30 degrees Celsius at room temperature. This way, the effectiveness of the drug can be safely maintained for a long time.

Appearance

White rectangular tablet

Package unit

Bottle - 10 tablets/bottle, Bottle - 30 tablets/bottle, Bottle - 90 tablets/bottle, Bottle - 300 tablets/bottle